Objective To compare tumor necrosis factor α inhibitors directly regarding the rates of treatment
response, remission, and the drug survival rate in patients with rheumatoid arthritis (RA), …

Objectives. To determine possible differences in serious adverse effects among the 10
currently approved biological and targeted synthetic DMARDs (b/ts-DMARDs) for RA. Methods. …

… Comparisons between groups were made with the Fisher exact test for dichotomous responses
and the Mann–Whitney U test for non-dichotomous responses. Changes over time were …

Objective To assess the 6-month effectiveness of the first rituximab (RTX) course in
rheumatoid arthritis (RA) and to identify possible predictors of response. Method 10 European …

Objective To investigate disease activity, treatment response, and drug survival, and predictors
thereof, among Danish patients with psoriatic arthritis (PsA) receiving their first treatment …

Objective At 5 years' follow-up of early (<6 months) rheumatoid arthritis patients to (1) investigate
whether initial combination therapy with methotrexate (MTX) and ciclosporin (CSA) (n=…

… Comparisons between groups were made with Fisher's exact test for dichotomous responses
and the Mann-Whitney U test for nondichotomous responses. Changes over time were …

Objectives To investigate the incidence of cancer in arthritis patients treated with or without
TNFα inhibitors (TNF-I). Methods Arthritis patients from the DANBIO database were followed-…

A Danish multicentre study was undertaken of the manifestations, infections, thrombotic
events, survival and predictive factors of survival in 513 Danish patients with systemic lupus …

Objective To describe the frequency of treatment switching and outcomes among patients
with psoriatic arthritis (PsA) who switched tumor necrosis factor α inhibitor (TNFi) agents in …